MRNS - Marinus Pharmaceuticals, Inc.

NasdaqGM - NasdaqGM Real Time Price. Currency in USD
Currency in USD

Valuation Measures

Market Cap (intraday) 5319.3M
Enterprise Value 3248.24M
Trailing P/E N/A
Forward P/E 1-8.85
PEG Ratio (5 yr expected) 1N/A
Price/Sales (ttm)N/A
Price/Book (mrq)6.01
Enterprise Value/Revenue 3N/A
Enterprise Value/EBITDA 6-12.65

Financial Highlights

Fiscal Year

Fiscal Year Ends Dec 31, 2017
Most Recent Quarter (mrq)Mar 31, 2018


Profit Margin 0.00%
Operating Margin (ttm)0.00%

Management Effectiveness

Return on Assets (ttm)-30.19%
Return on Equity (ttm)-53.77%

Income Statement

Revenue (ttm)N/A
Revenue Per Share (ttm)N/A
Quarterly Revenue Growth (yoy)N/A
Gross Profit (ttm)N/A
EBITDA -19.62M
Net Income Avi to Common (ttm)-19.46M
Diluted EPS (ttm)-0.68
Quarterly Earnings Growth (yoy)N/A

Balance Sheet

Total Cash (mrq)52.02M
Total Cash Per Share (mrq)1.28
Total Debt (mrq)N/A
Total Debt/Equity (mrq)N/A
Current Ratio (mrq)29.94
Book Value Per Share (mrq)1.31

Cash Flow Statement

Operating Cash Flow (ttm)-18.12M
Levered Free Cash Flow (ttm)-11.38M

Trading Information

Stock Price History

Beta 3.68
52-Week Change 3469.23%
S&P500 52-Week Change 313.91%
52 Week High 39.87
52 Week Low 31.38
50-Day Moving Average 37.17
200-Day Moving Average 35.92

Share Statistics

Avg Vol (3 month) 3740.07k
Avg Vol (10 day) 3725.62k
Shares Outstanding 540.52M
Float 32.66M
% Held by Insiders 11.14%
% Held by Institutions 164.95%
Shares Short (Jun 15, 2018) 42.03M
Short Ratio (Jun 15, 2018) 42.26
Short % of Float (Jun 15, 2018) 45.42%
Short % of Shares Outstanding (Jun 15, 2018) 45.02%
Shares Short (prior month May 15, 2018) 42.23M

Dividends & Splits

Forward Annual Dividend Rate 4N/A
Forward Annual Dividend Yield 4N/A
Trailing Annual Dividend Rate 3N/A
Trailing Annual Dividend Yield 3N/A
5 Year Average Dividend Yield 4N/A
Payout Ratio 40.00%
Dividend Date 3N/A
Ex-Dividend Date 4N/A
Last Split Factor (new per old) 2N/A
Last Split Date 3N/A